Using the source provided, respond to all parts of the question.
1. Your response to the question should be provided in six parts: A, B, C, D, E, and F. Write the response to each part of the question in complete sentences. Use appropriate psychological terminology in your response.
Identify the research method used in the study.
State the operational definition of sleep onset latency in the study.
Describe the relationship between evening device usage and sleep onset latency as indicated by the data.
Identify one ethical guideline described in the study. Describe one way the researchers in the study applied this ethical guideline.
Explain the extent to which the research findings may or may not be generalizable to the entire population using specific and relevant evidence from the study.
Explain how the research findings support or refute the concept of the role of the suprachiasmatic nucleus (SCN) in the sleep-wake cycle.
Source
This study investigated how evening exposure to blue light from electronic devices affects sleep onset latency in an individual presenting with chronic sleep difficulties. The research aimed to explore the relationship between screen time behaviors and the biological mechanisms underlying sleep regulation, particularly focusing on circadian rhythms and the function of the suprachiasmatic nucleus (SCN) in regulating melatonin production.
Total N: 1
Recruitment: Patient M.R. was referred to the Sleep Disorders Clinic at a university medical center by her primary care physician following six months of persistent difficulty initiating sleep
Gender: Female (100%)
Race/Ethnicity: White/Caucasian (100%)¹
Age Range: N/A (single participant)
Age Mean: 34
Age SD: null
Compensation: Treatment services provided at reduced cost through university clinic
Pittsburgh Sleep Quality Index (PSQI)
Morningness-Eveningness Questionnaire (MEQ)
Beck Depression Inventory-II (BDI-II)
Actigraphy wrist monitor (ActiWatch Spectrum Plus)
Semi-structured clinical interview protocol
14-day sleep diary with electronic device usage log
Medical records from referring physician
Salivary melatonin collection kit
Step 1 (Intake Session): Patient M.R. completed informed consent procedures, during which confidentiality protections were explained, including that all identifying information would be replaced with a pseudonym and data would be stored on password-protected, encrypted servers accessible only to the research team.
Step 2 (Initial Clinical Interview): A 90-minute semi-structured interview was conducted to gather comprehensive history including sleep complaints, daily routines, electronic device usage patterns, medical history, and psychosocial factors. M.R. reported working as a marketing manager requiring extensive evening email correspondence.
Step 3 (Standardized Assessment Battery): Over two sessions, M.R. completed the PSQI to assess global sleep quality, the MEQ to determine chronotype, and the BDI-II to screen for comorbid depression. All instruments were administered and scored according to standardized protocols.
Step 4 (Baseline Monitoring Period - Weeks 1-2): M.R. wore an actigraphy monitor continuously and maintained a detailed sleep diary recording bedtime, estimated sleep onset, wake time, and minutes of electronic device use in the hour before bed. Salivary melatonin samples were collected at 9 PM, 10 PM, and 11 PM on three separate evenings.
Step 5 (3-Month Follow-Up): The assessment battery was re-administered, and actigraphy/diary monitoring was repeated for another 14-day period to examine patterns over time. Interview explored any changes in device usage or sleep behaviors.
Step 6 (6-Month Follow-Up): Final administration of all standardized measures, actigraphy monitoring, and exit interview were completed. Comprehensive review of all longitudinal data was conducted to identify patterns between electronic device usage and sleep onset latency.
Step 7 (Data Integration and Case Conceptualization): The clinical team reviewed all quantitative scores, behavioral observations, interview data, and medical records to develop an integrated understanding of the relationship between M.R.'s evening device usage and her sleep difficulties.
Sleep onset latency was measured as the number of minutes elapsed between the time the participant turned off the lights with the intention to sleep and the time of sustained sleep onset as detected by the actigraphy monitor (defined as 10 consecutive minutes of immobility). This objective measure was cross-referenced with the participant's self-reported estimates in the sleep diary. Electronic device usage was measured as the total minutes of exposure to light-emitting screens (smartphone, tablet, laptop, or television) during the 60-minute period immediately preceding the lights-off time, as recorded in the daily device log.
Confidentiality was maintained throughout the study by using a pseudonym (M.R.) in all written materials, storing all data on secure, encrypted servers with access limited to authorized research personnel, and ensuring that no personally identifying information appeared in any reports or publications.
The assessment data revealed a consistent positive correlation between M.R.'s electronic device usage before bed and her sleep onset latency. At baseline, when M.R. averaged 78 minutes of device use before bed, her mean sleep onset latency was 58 minutes—well above the clinically normal threshold of 20 minutes. As her device usage decreased to 52 minutes at 3-month follow-up, her sleep onset latency correspondingly decreased to 41 minutes. Most notably, when device usage dropped to 24 minutes at the 6-month assessment, her sleep onset latency normalized to 19 minutes. Salivary melatonin levels showed a corresponding pattern, with evening melatonin at 10 PM increasing from a suppressed 8.2 pg/mL at baseline to 22.4 pg/mL at 6 months, suggesting improved endogenous melatonin production as blue light exposure diminished.
Assessment Domain/Measure | Baseline | 3-Month Follow-Up | 6-Month Follow-Up | Clinical Interpretation |
|---|---|---|---|---|
Avg. Evening Device Usage (minutes)² | 78 min | 52 min | 24 min | Decreased over time |
Avg. Sleep Onset Latency (minutes) | 58 min | 41 min | 19 min | Decreased over time |
PSQI Global Score (0-21) | 14 | 10 | 5 | Poor → Good sleep quality |
MEQ Score (16-86) | 38 | 42 | 48 | Evening → Intermediate type |
BDI-II Score (0-63) | 18 | 12 | 7 | Mild → Minimal depression |
Salivary Melatonin at 10 PM (pg/mL) | 8.2 | 14.6 | 22.4 | Suppressed → Normal levels |
This in-depth study of Patient M.R. demonstrates a clear positive relationship between evening electronic device usage and sleep onset latency, with reductions in screen time corresponding to meaningful improvements in the ability to fall asleep. These findings are consistent with our understanding of circadian rhythms and the function of the suprachiasmatic nucleus (SCN) in regulating melatonin; specifically, the blue light emitted from electronic devices appears to have disrupted the SCN's signaling to the pineal gland, thereby suppressing melatonin secretion and delaying sleep onset. As M.R.'s device usage decreased, her evening melatonin levels normalized, supporting the hypothesis that blue light exposure was interfering with the SCN's role as the body's master biological clock. However, because only one person was studied, these findings cannot establish causation and may not generalize to other individuals, and the reliance on self-reported device usage data introduces the possibility of memory errors or social desirability bias affecting accuracy.
Thornton, R. J., Vasquez, M. L., & Chen, S. K. (2021). Evening blue light exposure and sleep onset difficulties: An intensive case study examination of circadian disruption. Journal of Sleep and Biological Rhythms, 43(2), 156-171. https://doi.org/10.1037/sbr0000892
00:00